Helsinn Investment Fund Investor
The Helsinn Investment Fund focuses on privately-owned companies with early stage technologies in Cancer Supportive Care, Cancer Diagnostics and Cancer Therapeutics, among other areas close to Helsinn’s interests such as dermatology, metabolism and gastro-intestinal disease. These technologies range from biotech to pharma, medical devices and food supplements.
As well as these investments, Helsinn International Services, Sarl, has signed collaboration agreements with Centre Scientifique de Monaco and Lyfebulb U.S.
Technology:
N/A
Headquarters:
Monaco, Principality of Monaco
Funding Status:
N/A
Investment Stage:
Early Stage Venture
Founded Date:
2016
Number Of Exists:
2
Employee Number:
11-50
Industry:
Preventive Medicine
Investor Type:
Venture Capital